Eric Stone, Velano Vascular: "Innovating the Obvious: The Complex Value of Simple Ideas"

Join us on Thursday, March 8, when Rosenman Institute Director Christine Winoto will interview Eric Stone, CEO and co-founder of Velano Vascular. Under Eric's leadership, Velano's PIVO needleless blood draw technology won FDA approval; the company raised $17 million this past March; and Velano has just been named to the 2017 Fierce 15 in Medtech.

Where & When

Room 212, Byers Hall, UCSF Mission Bay (1700 4th St., San Francisco)
5:00 to 6:30 PM, Thursday, March 8

Agenda

5:00 - 5:30 pm: Networking
5:30 - 6:30 pm: Talk and Q&A

About the Speaker

stone_eric_profiledetail.jpg

Eric M. Stone is the Chief Executive Officer and co-founder of Velano Vascular. A patient advocate and serial healthcare entrepreneur, Stone currently serves as National Trustee and a Committee Chair of the Crohn's and Colitis Foundation of America (CCFA). Prior to Velano, he served as Vice President of Sales and Marketing for Molecular Health, and earlier in his career launched a series of pioneering interventional cardiology devices for Abbott while based in Brussels, Belgium and California. Stone was a founding member of Model N's (NYSE: MODN) Life Sciences division, where he led marketing and business development. Stone began his career in Marketing with Trilogy Software, and has since co-founded social sector programs at Harvard and Wharton. He served for a decade on Harvard University's Alumni Association (HAA) Board of Directors. Stone is a Director of Vigilant Biosciences and an Advisor to multiple healthcare upstarts. Stone received an MBA from The Wharton School, a Master's from Harvard University, and a BA from the University of Pennsylvania. He lives with his wife and daughter in San Francisco.